Gene expression profile prospectively predicts peritoneal relapse after curative surgery of gastric cancer

Annals of Surgical Oncology

Volumn 17, Issue 4, 2010, Pages 1033-1042

  Takeno, Atsushi ^a   Takemasa, Ichiro ^a   Seno, Shigeto ^b   Yamasaki, Makoto ^a   Motoori, Masaaki ^c   Miyata, Hiroshi ^a   Nakajima, Kiyokazu ^a   Takiguchi, Shuji ^a   Fujiwara, Yoshiyuki ^a   Nishida, Toshiro ^a   Okayama, Toshitsugu ^d   Matsubara, Kenichi ^e   Takenaka, Yoichi ^b   Matsuda, Hideo ^b   Monden, Morito ^a   Mori, Masaki ^a   Doki, Yuichiro ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^d BioInformation Technology and Science (BITS) Co Ltd   (Japan)

^e DNA CHIP RESEARCH INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RELAPSE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; STOMACH CANCER; STOMACH SURGERY; TUMOR GROWTH;

AGED; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION PROFILING; HUMANS; LYMPHATIC METASTASIS; MALE; NEOPLASM RECURRENCE, LOCAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PERITONEAL NEOPLASMS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; VALIDATION STUDIES AS TOPIC;

EID: 77952090258     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0854-1     Document Type: Article

References (42)

1. E Otsuji T Yamaguchi K Sawai A Hagiwara H Taniguchi T Takahashi 1998 Recent advances in surgical treatment have improved the survival of patients with gastric carcinoma Cancer. 82 1233 1237 10.1002/(SICI)1097-0142(19980401)82: 7<1233::AID-CNCR4>3.0.CO;2-G 1:STN:280:DyaK1c7oslylsA%3D%3D 9529013 (Pubitemid 28155383)
2. CH Yoo SH Noh DW Shin SH Choi JS Min 2000 Recurrence following curative resection for gastric carcinoma Br J Surg. 87 236 242 10.1046/j.1365-2168.2000. 01360.x 1:STN:280:DC%2BD3c7jslymsQ%3D%3D 10671934 (Pubitemid 30088655)
3. W Yu I Whang I Suh A Averbach D Chang PH Sugarbaker 1998 Prospective randomized trial of early postoperative intraperitoneal chemotherapy as an adjuvant to resectable gastric cancer Ann Surg. 228 347 354 10.1097/00000658- 199809000-00007 1:STN:280:DyaK1cvhtlynuw%3D%3D 9742917 (Pubitemid 30191697)
4. S Fujimoto RD Shrestha M Kokubun, et al. 1990 Positive results of combined therapy of surgery and intraperitoneal hyperthermic perfusion for far-advanced gastric cancer Ann Surg. 212 592 596 10.1097/00000658-199011000- 00005 1:STN:280:DyaK3M%2FltleltQ%3D%3D 2241314
5. S Abe H Yoshimura H Tabara, et al. 1995 Curative resection of gastric cancer: limitation of peritoneal lavage cytology in predicting the outcome J Surg Oncol. 59 226 229 10.1002/jso.2930590405 1:STN:280:DyaK2Mzls1GnsA%3D%3D 7630168
6. K Taniguchi Y Yonemura N Nojima, et al. 1998 The relation between the growth patterns of gastric carcinoma and the expression of hepatocyte growth factor receptor (c-met), autocrine motility factor receptor, and urokinase-type plasminogen activator receptor Cancer. 82 2112 2122 10.1002/(SICI)1097- 0142(19980601)82:11<2112::AID-CNCR5>3.0.CO;2-X 1:STN:280: DyaK1c3nt1ahsw%3D%3D 9610690 (Pubitemid 28240817)
7. Y Ishii A Ochiai T Yamada, et al. 2000 Integrin alpha6beta4 as a suppressor and a predictive marker for peritoneal dissemination in human gastric cancer Gastroenterology. 118 497 506 10.1016/S0016-5085(00)70255-1 1:CAS:528:DC%2BD3cXit1SmsLg%3D 10702200 (Pubitemid 30140847)
8. MJ van de Vijver YD He LJ van't Veer, et al. 2002 A gene-expression signature as a predictor of survival in breast cancer N Engl J Med. 347 1999 2009 10.1056/NEJMoa021967 12490681 (Pubitemid 35461656)
9. LJ van 't Veer H Dai MJ van de Vijver, et al. 2002 Gene expression profiling predicts clinical outcome of breast cancer Nature 415 530 536 10.1038/415530a (Pubitemid 34130608)
10. CM Perou T Sorlie MB Eisen, et al. 2000 Molecular portraits of human breast tumours Nature. 406 747 752 10.1038/35021093 1:CAS:528: DC%2BD3cXmt1CnsLw%3D 10963602
11. TR Golub DK Slonim P Tamayo, et al. 1999 Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring Science. 286 531 537 10.1126/science.286.5439.531 1:CAS:528:DyaK1MXmvVOhu7g%3D 10521349
12. S Yoshioka I Takemasa H Nagano, et al. 2009 Molecular prediction of early recurrence after resection of hepatocellular carcinoma Eur J Cancer. 45 881 9 10.1016/j.ejca.2008.12.019 1:CAS:528:DC%2BD1MXisl2rsb0%3D 19167881
13. S Ramaswamy KN Ross ES Lander TR Golub 2003 A molecular signature of metastasis in primary solid tumors Nat Genet. 33 49 54 10.1038/ng1060 1:CAS:528:DC%2BD38XpvVeqs7w%3D 12469122 (Pubitemid 36068681)
14. JA Sparano S Paik 2008 Development of the 21-gene assay and its application in clinical practice and clinical trials J Clin Oncol. 26 721 728 10.1200/JCO.2007.15.1068 18258979 (Pubitemid 351264384)
15. F Cardoso L Van't Veer E Rutgers S Loi S Mook MJ Piccart-Gebhart 2008 Clinical application of the 70-gene profile: The MINDACT trial J Clin Oncol. 26 729 735 10.1200/JCO.2007.14.3222 18258980 (Pubitemid 351264385)
16. K Teramoto M Tada E Tamoto, et al. 2005 Prediction of lymphatic invasion/lymph node metastasis, recurrence, and survival in patients with gastric cancer by cDNA array-based expression profiling J Surg Res. 124 225 236 10.1016/j.jss.2004.10.003 1:CAS:528:DC%2BD2MXjtVyrsro%3D 15820252 (Pubitemid 40463722)
17. CN Chen JJ Lin JJ Chen, et al. 2005 Gene expression profile predicts patient survival of gastric cancer after surgical resection J Clin Oncol. 23 7286 7295 10.1200/JCO.2004.00.2253 1:CAS:528:DC%2BD2MXhtF2nsL3E 16145069 (Pubitemid 46202342)
18. M Motoori I Takemasa Y Doki, et al. 2006 Prediction of peritoneal metastasis in advanced gastric cancer by gene expression profiling of the primary site Eur J Cancer. 42 1897 1903 10.1016/j.ejca.2006.04.007 1:CAS:528:DC%2BD28XotFyltbs%3D 16831544 (Pubitemid 44149091)
19. M Motoori I Takemasa M Yano, et al. 2005 Prediction of recurrence in advanced gastric cancer patients after curative resection by gene expression profiling Int J Cancer. 114 963 968 10.1002/ijc.20808 1:CAS:528: DC%2BD2MXjsFWjsrY%3D 15645432 (Pubitemid 40504478)
20. A Dupuy RM Simon 2007 Critical review of published microarray studies for cancer outcome and guidelines on statistical analysis and reporting J Natl Cancer Inst. 99 147 157 10.1093/jnci/djk018 17227998
21. S Michiels S Koscielny C Hill 2005 Prediction of cancer outcome with microarrays: A multiple random validation strategy Lancet. 365 488 492 10.1016/S0140-6736(05)17866-0 1:CAS:528:DC%2BD2MXhtlSgt7s%3D 15705458 (Pubitemid 40215731)
22. Y Kurokawa R Matoba H Nagano, et al. 2004 Molecular prediction of response to 5-fluorouracil and interferon-alpha combination chemotherapy in advanced hepatocellular carcinoma Clin Cancer Res. 10 6029 6038 10.1158/1078-0432.CCR-04-0243 1:CAS:528:DC%2BD2cXnvVKqu7c%3D 15447987 (Pubitemid 39287507)
23. Y Wang CC Barbacioru D Shiffman, et al. 2007 Gene expression signature in peripheral blood detects thoracic aortic aneurysm PLoS ONE 2 1050 10.1371/journal.pone.0001050 (Pubitemid 351560118)
24. LJ Heyer S Kruglyak S Yooseph 1999 Exploring expression data: Identification and analysis of coexpressed genes Genome Res. 9 1106 1115 10.1101/gr.9.11.1106 1:CAS:528:DyaK1MXns12ktrc%3D 10568750
25. Y Kodera H Nakanishi S Ito, et al. 2002 Quantitative detection of disseminated free cancer cells in peritoneal washes with real-time reverse transcriptase-polymerase chain reaction: A sensitive predictor of outcome for patients with gastric carcinoma Ann Surg. 235 499 506 10.1097/00000658- 200204000-00007 11923605 (Pubitemid 34258348)
26. K Mori K Aoyagi T Ueda, et al. 2004 Highly specific marker genes for detecting minimal gastric cancer cells in cytology negative peritoneal washings Biochem Biophys Res Commun. 313 931 937 10.1016/j.bbrc.2003.12.025 1:CAS:528:DC%2BD2cXosFer 14706632 (Pubitemid 38050082)
27. C Sakakura A Hagiwara M Nakanishi, et al. 2002 Differential gene expression profiles of gastric cancer cells established from primary tumour and malignant ascites Br J Cancer. 87 1153 1161 10.1038/sj.bjc.6600580 1:CAS:528:DC%2BD38XotFWrurw%3D 12402156 (Pubitemid 35422719)
28. A Barrier PY Boelle F Roser, et al. 2006 Stage II colon cancer prognosis prediction by tumor gene expression profiling J Clin Oncol. 24 4685 4691 10.1200/JCO.2005.05.0229 1:CAS:528:DC%2BD28XhtFynsr3N 16966692 (Pubitemid 46630932)
29. M Dettling 2004 BagBoosting for tumor classification with gene expression data Bioinformatics. 20 3583 3593 10.1093/bioinformatics/bth447 1:CAS:528:DC%2BD2cXhtVOjsr3I 15466910 (Pubitemid 40136794)
30. S Dudoit J Fridlyand TP Speed 2002 Comparison of discrimination methods for classification of tumors using gene expression data J Am Stat Assoc. 97 77 87 10.1198/016214502753479248 1:CAS:528:DC%2BD28Xht1SqtL7I
31. AH Bild G Yao JT Chang, et al. 2006 Oncogenic pathway signatures in human cancers as a guide to targeted therapies Nature. 439 353 357 10.1038/nature04296 1:CAS:528:DC%2BD28XkvF2mtg%3D%3D 16273092 (Pubitemid 43128862)
32. A Takeno I Takemasa Y Doki, et al. 2008 Integrative approach for differentially overexpressed genes in gastric cancer by combining large-scale gene expression profiling and network analysis Br J Cancer. 99 1307 1315 10.1038/sj.bjc.6604682 1:CAS:528:DC%2BD1cXht1Cmtr7L 18827816
33. S Jing D Wen Y Yu, et al. 1996 GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF Cell. 85 1113 1124 10.1016/S0092-8674(00)81311-2 1:CAS:528:DyaK28XjvF2iu7c%3D 8674117 (Pubitemid 26231176)
34. JJ Treanor L Goodman F de Sauvage, et al. 1996 Characterization of a multicomponent receptor for GDNF Nature. 382 80 83 10.1038/382080a0 1:CAS:528:DyaK28XjvFKjsrg%3D 8657309 (Pubitemid 26243362)
35. H Funahashi Y Okada H Sawai, et al. 2005 The role of glial cell line-derived neurotrophic factor (GDNF) and integrins for invasion and metastasis in human pancreatic cancer cells J Surg Oncol. 91 77 83 10.1002/jso.20277 1:CAS:528:DC%2BD2MXntVajsr4%3D 15999351 (Pubitemid 40967385)
36. G Spyrou E Enmark A Miranda-Vizuete J Gustafsson 1997 Cloning and expression of a novel mammalian thioredoxin J Biol Chem. 272 2936 2941 10.1074/jbc.272.5.2936 1:CAS:528:DyaK2sXpslGiug%3D%3D 9006939 (Pubitemid 27053344)
37. J Raffel AK Bhattacharyya A Gallegos, et al. 2003 Increased expression of thioredoxin-1 in human colorectal cancer is associated with decreased patient survival J Lab Clin Med. 142 46 51 10.1016/S0022-2143(03)00068-4 1:CAS:528:DC%2BD3sXls1ertbY%3D 12878985 (Pubitemid 36934520)
38. TM Grogan C Fenoglio-Prieser R Zeheb, et al. 2000 Thioredoxin, a putative oncogene product, is overexpressed in gastric carcinoma and associated with increased proliferation and increased cell survival Hum Pathol. 31 475 481 10.1053/hp.2000.6546 1:CAS:528:DC%2BD3cXjsFCgtb0%3D 10821495 (Pubitemid 30262870)
39. A Rubartelli N Bonifaci R Sitia 1995 High rates of thioredoxin secretion correlate with growth arrest in hepatoma cells Cancer Res. 55 675 680 1:CAS:528:DyaK2MXjtlyktbg%3D 7834639
40. S Toyokuni K Okamoto J Yodoi H Hiai 1995 Persistent oxidative stress in cancer FEBS Lett. 358 1 3 10.1016/0014-5793(94)01368-B 1:CAS:528: DyaK2MXjsFanur4%3D 7821417
41. T Noike S Miwa J Soeda A Kobayashi S Miyagawa 2008 Increased expression of thioredoxin-1, vascular endothelial growth factor, and redox factor-1 is associated with poor prognosis in patients with liver metastasis from colorectal cancer Hum Pathol. 39 201 208 10.1016/j.humpath.2007.04.024 1:CAS:528:DC%2BD1cXovFKqtw%3D%3D 17949784
42. S Sakuramoto M Sasako T Yamaguchi, et al. 2007 Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine N Engl J Med. 357 1810 1820 10.1056/NEJMoa072252 1:CAS:528:DC%2BD2sXht1Kit7bI 17978289 (Pubitemid 350044801)